drug

clazakizumab

1 story · latest Aug 27, 2026

Status: Investigational
Codes: CSL300, LY5724886
Trials: 2 registered trials in coverage

Relationships

Developed by Eli Lilly

Developed by CSL

Timeline

Lilly registers four new trials: Alzheimer's, cardiovascular, obesity, Crohn's programs

Aug 27Weekly roundup, 5 itemsclazakizumab Eli Lilly

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.